Sergio Pichuantes

Novartis Vaccines And Diagnostics, Inc.

$4,607,817

Attributed

$4,607,817

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2005–07

$2M$1.5M$1M$500K$0

'05

'06

'07

Funding mix

By agency

NIH$4,607,817 · 1

By mechanism

U01$4,607,817 · 1

Top collaborators

No co-investigators on record.

Most similar at Novartis Vaccines And Diagnostics, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Diagnosis Design /Evaluation”

Bruce J Hillman · American College Of Radiology$89,322,170
Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
David Sidransky · Johns Hopkins University$23,938,880
Philip J Disaia · University Of California Irvine$21,551,991
Constantine A. Gatsonis · Miriam Hospital$18,065,686
Rohit Varma · University Of Southern California$15,938,326

Research focus

Diagnosis Design /EvaluationSin Nombre VirusImmunoglobulin GNucleic Acid Quantitation /DetectionBioterrorism /Chemical WarfareSerology /SerodiagnosisGenotypeImmunoglobulin MHantavirusMajor Histocompatibility ComplexFlow CytometryDiagnostic TestsCellular ImmunityPeromyscusBiotechnologyRapid DiagnosisVirus AntigenCooperative StudyHuman SubjectAnimal BreedingCommunicable Disease DiagnosisClinical ResearchPatient Oriented ResearchVirus Infection Mechanism

Grant awards (5)

Development of Rapid Diagnostic Tests for Hantaviruses$964,654

U01 · FY2007 · AI · contact PI

Development of Rapid Diagnostic Tests for Hantaviruses$969,961

U01 · FY2006 · AI · contact PI

Development of Rapid Diagnostic Tests for Hantaviruses$1,060,253

U01 · FY2005 · AI

Development of Rapid Diagnostic Tests for Hantaviruses$1,074,529

U01 · FY2004 · AI

Development of Rapid Diagnostic Tests for Hantaviruses$538,420

U01 · FY2003 · AI